TM4SF1 and hepatocellular carcinoma: Our previous studies showed that 86% of patients with hepatitis B virus-related hepatocellular carcinoma have overexpressed TM4SF1 in their liver cancer cells, but that adjacent normal tissues and normal liver tissues had no measureable expression of TM4SF1 [3].